Metraipolis › archive › dc_a7aba44e2b8f
Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS) — Europe PMC PMID:41168830
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41168830
- DOI
- 10.1186/s13023-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T22:48:29.625Z
- SHA-256 of the archived text
715bbbc2b683b32dc94d68de292efcce6ae6daad211bfc5dc7740a61f86d0098- Stable URL of this page
https://metraipolis.com/documento/dc_a7aba44e2b8f
How to cite
Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS) — Europe PMC PMID:41168830 — Europe PMC (en), https://europepmc.org/article/MED/41168830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7aba44e2b8f (Metraipolis archive dc_a7aba44e2b8f, sha256 715bbbc2b683b32dc94d68de292efcce6ae6daad211bfc5dc7740a61f86d0098)
BibTeX
@misc{dca7aba44e2b8f,
title = {Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS) — Europe PMC PMID:41168830},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41168830},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7aba44e2b8f; sha256 715bbbc2b683b32dc94d68de292efcce6ae6daad211bfc5dc7740a61f86d0098},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41168830. Agents can read the archived copy with the MCP tool read_document.